Transamerica Financial Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $94.4K | Sell |
243
-794
| -77% | -$294K | 0.01% | 598 |
|
|
2026
Q1 | $304K | Buy |
1,037
+91
| +10% | +$29.9K | 0.03% | 332 |
|
|
2025
Q4 | $332K | Sell |
946
-72
| -7% | -$24.3K | 0.03% | 293 |
|
|
2025
Q3 | $329K | Buy |
1,018
+402
| +65% | +$125K | 0.03% | 270 |
|
|
2025
Q2 | $239K | Buy |
616
+188
| +44% | +$75.6K | 0.02% | 216 |
|
|
2025
Q1 | $186K | Buy |
428
+222
| +108% | +$89.1K | 0.02% | 224 |
|
|
2024
Q4 | $76K | Buy |
206
+205
| +20,500% | +$85.8K | 0.01% | 281 |
|
|
2024
Q3 | $1K | Buy |
+1
| New | +$534 | ﹤0.01% | 454 |
|
|
2020
Q3 | – | Sell |
-846
| Closed | -$223K | – | 251 |
|
|
2020
Q2 | $223K | Buy |
+846
| New | +$226K | 0.05% | 155 |
|
|
2019
Q3 | – | Sell |
-661
| Closed | -$187K | – | 203 |
|
|
2019
Q2 | $187K | Buy |
+661
| New | +$181K | 0.04% | 169 |
|
|
2019
Q1 | – | Sell |
-579
| Closed | -$152K | – | 190 |
|
|
2018
Q4 | $152K | Sell |
579
-176
| -23% | -$48.4K | 0.04% | 164 |
|
|
2018
Q3 | $207K | Sell |
755
-52
| -6% | -$13.5K | 0.04% | 177 |
|
|
2018
Q2 | $192K | Sell |
807
-24,572
| -97% | -$5.69M | 0.04% | 183 |
|
|
2018
Q1 | $5.58M | Sell |
25,379
-4,186
| -14% | -$983K | 0.82% | 42 |
|
|
2017
Q4 | $6.65M | Sell |
29,565
-545
| -2% | -$116K | 0.88% | 35 |
|
|
2017
Q3 | $5.72M | Buy |
+30,110
| New | +$5.73M | 0.71% | 52 |
|
|
2017
Q2 | – | Sell |
-30,092
| Closed | -$4.98M | – | 407 |
|
|
2017
Q1 | $4.98M | Sell |
30,092
-153
| -0.5% | -$24.3K | 0.6% | 55 |
|
|
2016
Q4 | $4.35M | Buy |
30,245
+1,035
| +4% | +$139K | 0.52% | 65 |
|
|
2016
Q3 | $3.66M | Buy |
29,210
+2,640
| +10% | +$341K | 0.4% | 72 |
|
|
2016
Q2 | $3.49M | Sell |
26,570
-441
| -2% | -$60.3K | 0.35% | 77 |
|
|
2016
Q1 | $3.75M | Buy |
27,011
+21,009
| +350% | +$2.81M | 0.32% | 77 |
|
|
2015
Q4 | $837K | Buy |
6,002
+361
| +6% | +$49.7K | 0.06% | 183 |
|
|
2015
Q3 | $790K | Buy |
5,641
+5,637
| +140,925% | +$847K | 0.06% | 172 |
|
|
2015
Q2 | $1K | Sell |
4
-34
| -89% | -$5.43K | ﹤0.01% | 797 |
|
|
2015
Q1 | $6K | Sell |
38
-2,556
| -99% | -$364K | ﹤0.01% | 679 |
|
|
2014
Q4 | $326K | Buy |
2,594
+252
| +11% | +$31.1K | 0.03% | 243 |
|
|
2014
Q3 | $281K | Sell |
2,342
-115
| -5% | -$13.2K | 0.03% | 231 |
|
|
2014
Q2 | $265K | Buy |
2,457
+368
| +18% | +$37.9K | 0.02% | 250 |
|
|
2014
Q1 | $208K | Buy |
2,089
+162
| +8% | +$14.7K | 0.02% | 257 |
|
|
2013
Q4 | $178K | Buy |
+1,927
| New | +$171K | 0.02% | 252 |
|
Other funds holding ELV
Transamerica Financial Advisors's ELV Position: Q2 2026 in Review
Transamerica Financial Advisors reduced its Elevance Health (ELV) stake by 77% in Q2 2026, selling an estimated $294K and leaving 243 shares worth $94.4K. The position accounts for 0.01% of the portfolio, ranked #598.
Transamerica Financial Advisors first reported a position in ELV in Q4 2013 and has held it in 30 quarters since. The position peaked at $6.65M in Q4 2017. 1,600 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Transamerica Financial Advisors held 243 shares of Elevance Health worth $94.4K as of Q2 2026.
- Transamerica Financial Advisors sold 794 Elevance Health shares in Q2 2026, an estimated $294K.
- Elevance Health made up 0.01% of Transamerica Financial Advisors's portfolio in Q2 2026, its #598 holding.
- Transamerica Financial Advisors first reported a position in Elevance Health in Q4 2013 and has held it in 30 quarters since.
- Transamerica Financial Advisors's Elevance Health position peaked at $6.65M in Q4 2017.
- 1,600 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Transamerica Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.